Targeted sequencing has become an essential approach in genomics research and applied sequencing workflows, allowing laboratories to focus analytical power on specific regions of interest rather than sequencing entire genomes. By concentrating sequencing resources, labs can improve data relevance, reduce unnecessary reads, and manage project budgets more effectively.
Among targeted sequencing strategies, hybrid capture sequencing and amplicon sequencing are the two most commonly adopted methods. While both approaches are capable of delivering high-quality targeted data, they differ significantly in terms of cost structure, workflow complexity, scalability, and overall efficiency. These differences become especially important as laboratories scale projects, manage recurring studies, or operate under tight budget constraints.
For many targeted applications, amplicon sequencing has emerged as the more cost-efficient option. Paragon Genomics develops targeted sequencing solutions that are specifically designed to reduce workflow burden and sequencing waste while maintaining high performance and reproducibility.
Understanding Hybrid Capture and Amplicon Sequencing
Hybrid Capture Sequencing Overview
Hybrid capture sequencing enriches target regions using sequence-specific probes that hybridize to DNA fragments of interest. After binding, these fragments are captured, washed, and prepared for sequencing. This enrichment strategy allows for broad coverage and is often selected for large gene panels or exploratory studies where targets may evolve.
One of the primary strengths of hybrid capture is flexibility. Panels can be expanded with additional probes, and the method tolerates a wide range of fragment sizes. However, this flexibility comes at a cost. Probe synthesis and enrichment reagents are expensive, and the workflow involves multiple steps that increase hands-on time and variability.
Hybrid capture workflows also tend to generate a notable proportion of off-target reads. To achieve sufficient coverage across all targets, laboratories often need to sequence deeper than initially planned, increasing sequencing costs and downstream data processing demands.
Amplicon Sequencing Overview
Amplicon sequencing uses PCR to selectively amplify predefined genomic regions before sequencing. Rather than enriching fragments after library preparation, the method amplifies only the desired targets from the outset. This targeted amplification dramatically improves on-target efficiency and reduces wasted sequencing reads.
Amplicon sequencing is particularly effective for applications with well-defined targets, such as known variants, hotspot regions, or focused gene panels. The workflow is typically faster and more streamlined than hybrid capture, making it well-suited for studies requiring rapid turnaround or consistent repeat testing.
CleanPlex NGS Amplicon Sequencing from Paragon Genomics is designed to deliver uniform amplification across targets while minimizing workflow complexity and reagent usage.
Key Cost Drivers in Hybrid Capture vs Amplicon Sequencing
Panel Size and Target Complexity
Panel size plays a central role in determining overall sequencing cost. Hybrid capture becomes more expensive as panels grow due to increased probe requirements and enrichment complexity. Large panels also require higher sequencing depth to ensure adequate coverage across all targets.
Amplicon sequencing is inherently more cost-efficient for small to medium-sized panels. By focusing amplification exclusively on relevant regions, laboratories avoid spending resources on unnecessary genomic content. This efficiency is particularly valuable for studies with stable, predefined targets.
Paragon Genomics supports targeted panel design strategies that help laboratories balance coverage needs with cost control, ensuring sequencing resources are applied where they matter most.
Reagent and Consumable Costs
Hybrid capture workflows rely on multiple enrichment steps, each requiring dedicated reagents, wash buffers, and consumables. These additional materials contribute significantly to per-sample cost and increase supply chain complexity.
Amplicon sequencing workflows are more reagent-efficient by design. The reduced number of steps lowers material consumption and simplifies inventory management. In most amplicon-based workflows:
- Fewer reagents are required overall
- Library preparation kits are more compact
- Per-sample reagent costs are easier to predict
CleanPlex workflows are engineered to maintain amplification performance while minimizing reagent waste, helping laboratories keep recurring costs under control.
Labor and Workflow Efficiency
Labor costs are often one of the largest hidden expenses in sequencing projects. Hybrid capture workflows are time-intensive and require experienced staff to manage probe hybridization, enrichment steps, and quality control checkpoints.
Amplicon sequencing significantly reduces hands-on time by simplifying library preparation. Faster workflows allow labs to process more samples per run without increasing staffing requirements. This efficiency is particularly important for facilities handling ongoing or high-volume sequencing projects.
CleanPlex NGS Amplicon Sequencing further reduces workflow complexity, supporting consistent results with fewer manual interventions and shorter preparation timelines.
Sequencing Depth and Data Analysis Costs
Hybrid capture methods often require deeper sequencing to compensate for off-target reads. This increased sequencing depth raises run costs and generates larger datasets that require more computational resources to analyze and store.
Amplicon sequencing produces highly focused datasets with minimal background noise. As a result:
- Required sequencing depth is lower
- Data analysis pipelines are more straightforward
- Computational and storage costs are reduced
These efficiencies make amplicon sequencing particularly attractive for laboratories seeking predictable costs and faster data turnaround.
When Amplicon Sequencing Is the More Cost-Efficient Choice
Amplicon sequencing is most cost-effective when studies prioritize targeted precision over broad genomic coverage. Projects with clearly defined targets benefit the most from this focused approach.
Amplicon-based workflows are especially well-suited for:
- Small to medium-sized gene panels
- High-throughput screening studies
- Validation and follow-up research
- Time-sensitive sequencing applications
CleanPlex NGS Amplicon Sequencing enables laboratories to scale these projects efficiently while maintaining uniform coverage, reproducibility, and consistent cost control.
Considerations Beyond Cost
Although cost efficiency is a primary concern, other performance factors should be considered when choosing a sequencing method. Amplicon sequencing delivers high sensitivity due to deep, uniform coverage of target regions, making it well-suited for detecting low-frequency variants.
Turnaround time is another important factor. Amplicon workflows support faster library preparation and sequencing schedules, which is increasingly important in both research and applied sequencing environments.
While hybrid capture allows easier expansion of very large panels, modern amplicon solutions such as CleanPlex are designed with adaptability in mind. Panels can be updated or refined without introducing major workflow disruptions or cost spikes.
Choosing the Right Strategy for Your Laboratory
Selecting the appropriate sequencing approach requires aligning technical requirements with operational constraints. Laboratories must consider panel size, sample volume, turnaround expectations, and long-term cost sustainability.
For many targeted sequencing applications, amplicon sequencing provides a balance of efficiency, scalability, and cost predictability. Paragon Genomics supports laboratories in optimizing targeted sequencing strategies by offering solutions that simplify workflows while maintaining high data quality.
Careful method selection allows labs to achieve reliable results while maximizing return on sequencing investment.
A direct cost comparison between hybrid capture and amplicon sequencing shows that amplicon-based approaches are often the more efficient option for targeted studies, as reduced reagent usage, streamlined workflows, lower sequencing depth requirements, and simplified data analysis all contribute to meaningful cost savings. For laboratories seeking a focused, scalable, and cost-efficient targeted sequencing solution, CleanPlex NGS Amplicon Sequencing from Paragon Genomics delivers consistent performance with predictable economics.
Paragon Genomics
Start Building Your CleanPlex Custom NGS Panel
Ready to create a pharmacogenomics panel that fits your research goals? CleanPlex Custom NGS Panels offer flexibility, fast turnaround, and expert support to help you build smarter NGS assays. To create a custom panel for pharmacogenomics profiling, schedule a free consultation below by entering your email address.
Related Blog

Overview of Next-Generation Sequencing, Targeted Sequencing and CleanPlex Technology for Precision Medicine and Research

Overview of Next-Generation Sequencing, Targeted Sequencing and CleanPlex Technology for Precision Medicine and Research Select Options

